J. Goldman & CO LP Petros Pharmaceuticals, Inc. Call Options Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	BUY	$1.33 - $4.09 $41,562 - $127,812	31,250 New	31,250 $0
Q3 2021 Nov 15, 2021	SELL	$1.82 - $3.2 $56,875 - $100,000	-31,250 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.24 - $4.68 $101,250 - $146,250	31,250 New	31,250 $0

Ticker PTPI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,708,000
Market Cap $5.18M
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.